Axsome Therapeutics is currently under scrutiny as its options flow reveals a pronounced skew towards put options. This trend suggests that investors are anticipating potential negative outcomes ahead of an important binary catalyst.
The heavy put activity indicates a prevailing bearish sentiment among traders, who may be hedging against possible adverse news or results from the upcoming event. Such market behavior often reflects uncertainty regarding the company's future prospects.
As the catalyst approaches, market participants will be closely monitoring Axsome's developments, with the potential for significant price movements based on the outcomes of this event. Investors are advised to stay informed and consider the implications of this options activity.